Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Medtronic's Percept™ DBS neurostimulators now incorporate BrainSense™ Adaptive technology, which allows the system to automatically adjust therapy without manual intervention by patients or ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

Medtronic plc, a Galway-headquartered global leader in healthcare technology, announced the US FDA has approval of BrainSense adaptive Deep Brain Stimulation (aDBS) and BrainSense Electrode Identifier ...

Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

Medtronic Neuroscience President Brett ... Monday’s announcement includes approval for the BrainSense adaptive deep-brain ...